Alanosine in Treating Patients With Cancer

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
7663
Conditions: Lung Cancer|Malignant Mesothelioma|Pancreatic Cancer|Sarcoma
Start Date: March 1, 2003
Phase: Phase II
Status: Completed
NCT ID: NCT00062283
Study Type: Interventional
Intervention: Drug: L-alanosine
Study Design: Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: Memorial Sloan-Kettering Cancer Center|National Cancer Institute (NCI)
Ages: Child|Adult|Senior
Enrollment: 0
Funded By: Other|NIH
First Received: June 5, 2003
End Date:
Last Updated: December 11, 2009
Last Verified: December 1, 2009